A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 346 participants.
Also called NCT04754334
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 346 participants
- Sponsor
- Registry
-
NCT04754334
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT04754334. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-16 (actual); primary completion 2023-01-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
- Condition
- T2DM (Type 2 Diabetes Mellitus)
- Intervention (Drug)
- ORMD-0801
- Intervention (Other)
- Placebo
- Lead sponsor
- Oramed, Ltd.
- Collaborator
- Integrium
Record details
- Record id
cardio:ct-nct04754334- Content hash
2ee882f9a9cacd16863bb33801ea2a493c1f377fb90eab237bbbeda3cbdac5ca